3. Objectives
 By the end of this lecture the student should be able to:Â
    Understand the normal stucture of Haemoglobin
⢠Know the Diverse group of disorders which manifest
as anemia of varying degrees.
⢠Know the defective production of globin portion of
hemoglobin molecule.
⢠Know the Distribution of disease worldwide.
⢠Describe the disease either homozygous or
heterozygous defect.
⢠Know the Defect results from abnormal rate of
synthesis in one of the globin chains.
15. β-Thalassaemia
An absence or deficiency of β-chain synthesis of adult HbA
β Chain synthesis
Hb-A
γ and δ chain
Hb-A = ι2β2
16. On the basis of synthetic ability β-genes
are designated as
⢠β gene â can synthesize normal amount
of β-chain
⢠β+
gene â can synthesize reduced
amount of β-chain
⢠β0
gene â cannot synthesize β-chain
17. Pathophysiology of β-Thalassaemia
Various mutation in β-gene
Complete or partial absence of β-chain
Decreased adult HbA
Îą-chain synthesis remain normal
Free complementary Îą-chain â unstable and
precipitate within normoblasts as insoluble
inclusions
Cell membrane damage & impaired DNA synthesis
ď apoptosis i.e. ineffective erythropoeisis
18. 70-80% marrow normoblasts undergo apoptosis
Inclusion bearing red cells undergo
sequestration & destruction in spleen
19. Partial or lack of HbA synthesis ď âMCHC &
MCH ď Hypochromia & microcytosis
Norm
al
Thalassae
mia
20. âHaemolysis ď âdemands of phagocytic
function ď hyperplasia of phagocytes
ď Hepatosplenomegaly
To compensate anaemia extramedullary
haemopoiesis in liver, spleen & brain
ď Organomegaly
22. Classification & Terminology
Beta Thalassemia
⢠Normal β/β
⢠Minor β/β0
β/β+
⢠Intermedia β0
/β+
β+
/β+
⢠Major β0
/β0
β+
/β+
β0
/β+
23. Classical Syndromes of Beta
Thalassemia
âşSilent carrier state â the mildest form of beta
thalassemia.
âşBeta thalassemia minor - heterozygous
disorder resulting in mild hypochromic,
microcytic hemolytic anemia.
âşBeta thalassemia intermedia - Severity lies
between the minor and major.
âşBeta thalassemia major - homozygous
disorder resulting in severe transfusion-
dependent hemolytic anemia.
23
24. Silent Carrier State for β
Thalassemia
âşAre various heterogenous beta mutations that
produce only small decrease in production of
beta chains.
âşPatients have nearly normal beta/alpha chain
ratio and no hematologic abnormalities.
âşHave normal levels of Hb A2.
24
25. Beta Thalassemia Minor
âşCaused by heterogenous mutations that affect beta
globin synthesis.
âşUsually presents as mild, asymptomatic hemolytic
anemia unless patient in under stress such as pregnancy,
infection, or folic acid deficiency.
âşHave one normal beta gene and one mutated beta gene.
âşHemoglobin level in 10-13 g/dL range with normal or
slightly elevated RBC count.
25
26. Beta Thalassemia Minor
âşAnemia usually hypochromic and microcytic with
slight aniso and poik, including target cells and
elliptocytes; May see basophilic stippling.
âşRarely see hepatomegaly or splenomegaly.
âşHave high Hb A2 levels (3.5-8.0%) and normal to
slightly elevated Hb F levels.
âşAre different variations of this form depending upon
which gene has mutated.
âşNormally require no treatment.
âşMake sure are not diagnosed with iron deficiency
anemia.
26
27. Beta Thalassemia Intermedia
âşPatients able to maintain minimum hemoglobin (7 g/dL
or greater) without transfusions.
âşExpression of disorder falls between thalassemia minor
and thalassemia major. May be either heterozygous for
mutations causing mild decrease in beta chain
production, or may be homozygous causing a more
serious reduction in beta chain production.
âşSee increase in both Hb A2 production and Hb F
production.
âşPeripheral blood smear picture similar to thalassemia
minor.
27
28. Beta Thalassemia Intermedia
âşHave varying symptoms of anemia, jaundice,
splenomegaly and hepatomegaly.
âşHave significant increase in bilirubin levels.
âşAnemia usually becomes worse with infections,
pregnancy, or folic acid deficiencies.
âşMay become transfusion dependent as adults.
âşTend to develop iron overloads as result of increased
gastrointestinal absorption.
âşUsually survive into adulthood.
28
29. Beta Thalassemia Major 1 of 3
âşCharacterized by severe microcytic, hypochromic
anemia.
âşDetected early in childhood:
â Infants fail to thrive.
â Have pallor, variable degree of jaundice, abdominal
enlargement, and hepatosplenomegaly.
âşHemoglobin level between 4 and 8 gm/dL.
âşSevere anemia causes marked bone changes due to
expansion of marrow space for increased
erythropoiesis.
âşSee characteristic changes in skull, long bones, and
hand bones. 29
30. Beta Thalassemia Major 2 of 3
âşHave protrusion upper teeth and Mongoloid facial
features.
âşPhysical growth and development delayed.
âşPeripheral blood shows markedly hypochromic,
microcytic erythrocytes with extreme poikilocytosis,
such as target cells, teardrop cells and elliptocytes. See
marked basophilic stippling and numerous NRBCs.
âşMCV in range of 50 to 60 fL.
âşLow retic count seen (2-8%).
âşMost of hemoglobin present is Hb F with slight
increase in Hb A2.
30
31. Beta Thalassemia Major 3 of 3
âşRegular transfusions usually begin around one year of
age and continue throughout life.
âşExcessive number of transfusions results in tranfusional
hemosiderosis; Without iron chelation, patient
develops cardiac disease.
âşDanger in continuous tranfusion therapy:
â Development of iron overload.
â Development of alloimmunization (developing antibodies to
transfused RBCs).
â Risk of transfusion-transmitted diseases.
âşBone marrow transplants may be future treatment,
along with genetic engineering and new drug therapies.
31
35. Classification & Terminology
Alpha Thalassemia
⢠Normal ιι/ιι
⢠Silent carrier - ι/ιι
⢠Minor -ι/-ι
--/ιι
⢠Hb H disease --/-ι
⢠Barts hydrops fetalis --/--
36. Alpha Thalassemias
⢠Result from gene deletions
⢠One deletionâSilent carrier; no clinical
significance
⢠Two deletionsâÎą Thal trait; mild hypochromic
microcytic anemia
⢠Three deletionsâHgb H; variable severity, but
less severe than Beta Thal Major
⢠Four deletionsâBartâs Hgb; Hydrops Fetalis;
In Utero or early neonatal death
37. Alpha Thalassemia 2 of 2
âşPredominant cause of alpha thalassemias is large
number of gene deletions in the alpha-globin gene.
âşAre four clinical syndromes present in alpha
thalassemia:
â Silent Carrier State
â Alpha Thalassemia Trait (Alpha Thalassemia Minor)
â Hemoglobin H Disease
â Bart's Hydrops Fetalis Syndrome
37
38. Silent Carrier State
âşDeletion of one alpha gene, leaving
three functional alpha genes.
âşAlpha/Beta chain ratio nearly normal.
âşNo hematologic abnormalities
present.
38
39. Alpha Thalassemia Trait
(Alpha Thalassemia Minor)
âşAlso called Alpha Thalassemia Minor.
âşCaused by two missing alpha genes. May be
homozygous (-a/-a) or heterozygous (--/aa).
âşExhibits mild microcytic, hypochromic anemia.
âşMay be confused with iron deficiency anemia.
âşAlthough some Bart's hemoglobin (Îł4) present at birth,
no Bart's hemoglobin present in adults.
39
40. Hemoglobin H Disease 1 of 2
âşSecond most severe form alpha thalassemia.
âşUsually caused by presence of only one gene producing
alpha chains (--/-a).
âşResults in accumulation of excess unpaired gamma or
beta chains. Born with 10-40% Bart's hemoglobin (Îł4).
Gradually replaced with Hemoglobin H (β4). In adult,
have about 30-50% Hb H.
γ4 β4
40
41. Bartâs Hydrops Fetalis
Syndrome
âşMost severe form. Incompatible with life. Have no functioning
alpha chain genes (--/--).
âşBaby born with hydrops fetalis, which is edema and ascites
caused by accumulation serous fluid in fetal tissues as result of
severe anemia. Also see hepatosplenomegaly and cardiomegaly.
âşPredominant hemoglobin is Hemoglobin Bart, along with
Hemoglobin Portland and traces of Hemoglobin H.
âşHemoglobin Bart's has high oxygen affinity so cannot carry
oxygen to tissues. Fetus dies in utero or shortly after birth. At
birth, see severe hypochromic, microcytic anemia with numerous
NRBCs.
âşPregnancies dangerous to mother. Increased risk of toxemia and
severe postpartum hemorrhage.
41